People news: Synovate Healthcare and Durata Therapeutics

Share this article:

Market research agency Synovate Healthcare has hired Paul Villa as SVP, payer and market access research. Villa joins Synovate from Genactis, a global research based consultancy where he was VP responsible for leading US pricing and reimbursement projects.

Durata Therapeutics announced the formation of its senior leadership team, including Paul Edick as CEO, Corey Fishman as COO and Dr. Michael Dunne as chief medical officer. Edick has worked at Johnson & Johnson, G.D. Searle and Pharmacia; Fishman at Monsanto, Searle and Pharmacia; and Dunne at Pfizer.

This material may not be published, broadcast, rewritten or redistributed in any form without prior authorization. Your use of this website constitutes acceptance of Haymarket Media's Privacy Policy and Terms & Conditions